Kala Bio KALA
NASDAQ KALA
$0.82 -0.02 (-2.39%)
As of: Aug 21, 2026 · 3:58 PM EDT

Kala Bio (KALA) Depreciation & Amortization (CF) (2016 - 2025)

Kala Bio (KALA) posted Depreciation & Amortization (CF) of $54000.0 for Q4 2025, down 57.81% sequentially from $128000.0 in Q3 2025, and down 21.74% YoY from $69000.0 in Q4 2024.

Kala Bio (KALA) Depreciation & Amortization (CF) (2016 - 2025) Analysis & Trends

Kala Bio has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $54000.0 in Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 21.74% year-over-year to $54000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $249000.0 (down 4.6% YoY) and the FY2025 annual result came in at $317000.0, up 22.39% from the prior year.
  • Depreciation & Amortization (CF) declined to $54000.0 in Q4 2025 per KALA's latest filing, from $128000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $259000.0 in Q3 2021 and troughed at $54000.0 in Q4 2025.
  • A 5-year average of $119550.0 and a median of $78000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) slumped 62.26% in 2022, then jumped 103.17% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $212000.0 in 2021, then plunged by 62.26% to $80000.0 in 2022, then retreated by 12.5% to $70000.0 in 2023, then retreated by 1.43% to $69000.0 in 2024, then fell by 21.74% to $54000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $54000.0, $128000.0, and $67000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 40.52 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 191.83 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Kala Bio 9.89 Mn 9.89 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 54,000.00
Dec 31, 2025 54,000.00
Sep 30, 2025 128,000.00
Sep 30, 2025 128,000.00
Jun 30, 2025 67,000.00
Jun 30, 2025 67,000.00
Mar 31, 2025 68,000.00
Mar 31, 2025 68,000.00
Dec 31, 2024 69,000.00
Dec 31, 2024 69,000.00
Sep 30, 2024 63,000.00
Sep 30, 2024 63,000.00
Jun 30, 2024 61,000.00
Jun 30, 2024 61,000.00
Mar 31, 2024 66,000.00
Mar 31, 2024 66,000.00
Dec 31, 2023 70,000.00
Dec 31, 2023 70,000.00
Sep 30, 2023 79,000.00
Sep 30, 2023 79,000.00